Nitric Oxide Synthase Type III
"Nitric Oxide Synthase Type III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in ENDOTHELIAL CELLS.
| Descriptor ID |
D052250
|
| MeSH Number(s) |
D08.811.682.664.500.772.750
|
| Concept/Terms |
Nitric Oxide Synthase Type III- Nitric Oxide Synthase Type III
- Nitric Oxide Synthase, Type III
- Endothelial Nitric Oxide Synthase
- ENOS Enzyme
- ECNOS Enzyme
- Endothelial Constitutive Nitric Oxide Synthase
|
Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Synthase Type III".
Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Synthase Type III".
This graph shows the total number of publications written about "Nitric Oxide Synthase Type III" by people in this website by year, and whether "Nitric Oxide Synthase Type III" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 7 | 12 | 19 |
| 2018 | 5 | 4 | 9 |
| 2019 | 5 | 4 | 9 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitric Oxide Synthase Type III" by people in Profiles.
-
Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems. Nitric Oxide. 2021 06 01; 111-112:64-71.
-
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses. 2021 Apr; 149:110539.
-
Does eNOS derived nitric oxide protect the young from severe COVID-19 complications? Ageing Res Rev. 2020 12; 64:101201.
-
Effect of Ergothioneine on 7-Ketocholesterol-Induced Endothelial Injury. Neuromolecular Med. 2021 03; 23(1):184-198.
-
High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia. Med Hypotheses. 2020 Oct; 143:110142.
-
Failure in the compensatory mechanism in red blood cells due to sustained smoking during pregnancy. Chem Biol Interact. 2019 Nov 01; 313:108821.
-
Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension. Circ Res. 2019 09 13; 125(7):678-695.
-
Downregulation of endothelin A receptor (ETaR) ameliorates renal ischemia reperfusion injury by increasing nitric oxide production. Life Sci. 2019 Jul 01; 228:295-304.
-
Effects of granulocyte colony-stimulating factor on rabbit carotid and porcine heart models of chronic obliterative arterial disease. Mol Med Rep. 2019 Jun; 19(6):4569-4578.
-
Effect of nitric oxide reduction on arterial thrombosis. Scand Cardiovasc J. 2019 02; 53(1):1-8.